Jeffrey Chodakewitz Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey Chodakewitz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Jeffrey Chodakewitz for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 155.57 | 23,479 | 3,652,628 | 23,479 | |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.00 | 10,125 | 0 | 74,785 | 64.7 K to 74.8 K (+15.66 %) |
| Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.00 | 12,136 | 0 | 64,660 | 52.5 K to 64.7 K (+23.11 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 109.14 | 3,594 | 392,249 | 14,375 | |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 164.71 | 100 | 16,471 | 52,524 | 52.6 K to 52.5 K (-0.19 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 164.12 | 900 | 147,708 | 52,624 | 53.5 K to 52.6 K (-1.68 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 162.94 | 400 | 65,176 | 53,524 | 53.9 K to 53.5 K (-0.74 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 161.51 | 500 | 80,755 | 53,924 | 54.4 K to 53.9 K (-0.92 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 160.50 | 500 | 80,250 | 54,424 | 54.9 K to 54.4 K (-0.91 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 159.62 | 700 | 111,734 | 54,924 | 55.6 K to 54.9 K (-1.26 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 158.32 | 494 | 78,210 | 55,624 | 56.1 K to 55.6 K (-0.88 %) |
| Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 109.14 | 3,594 | 392,249 | 56,118 | 52.5 K to 56.1 K (+6.84 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 14,368 | |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 14,368 | |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 169.49 | 100 | 16,949 | 52,524 | 52.6 K to 52.5 K (-0.19 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 169.49 | 100 | 16,949 | 52,524 | 52.6 K to 52.5 K (-0.19 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 168.06 | 100 | 16,806 | 52,624 | 52.7 K to 52.6 K (-0.19 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 168.06 | 100 | 16,806 | 52,624 | 52.7 K to 52.6 K (-0.19 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 166.10 | 996 | 165,436 | 52,724 | 53.7 K to 52.7 K (-1.85 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 166.10 | 996 | 165,436 | 52,724 | 53.7 K to 52.7 K (-1.85 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 165.23 | 600 | 99,138 | 53,720 | 54.3 K to 53.7 K (-1.10 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 165.23 | 600 | 99,138 | 53,720 | 54.3 K to 53.7 K (-1.10 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 54,320 | 52.5 K to 54.3 K (+3.42 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 54,320 | 52.5 K to 54.3 K (+3.42 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 167.44 | 1,900 | 318,136 | 52,524 | 54.4 K to 52.5 K (-3.49 %) |
| Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 167.44 | 1,900 | 318,136 | 52,524 | 54.4 K to 52.5 K (-3.49 %) |